Medpace Holdings, Inc.
MEDP- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001668397
In the last 90 days, Medpace Holdings, Inc. insiders filed 0 open-market purchases and 18 sales; 700 institutions reported holding it in 13F filings for Q2 2026, worth $13.1B in total; superinvestors Giverny Capital and Fundsmith hold it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $176.6M in total
- 18
- 13F holdersQ2 2026, −25 vs. previous quarter
- 700
- 13F valueReported value at the end of Q2 2026
- $13.1B
- Superinvestors holdingAt the end of Q2 2026
- 2
Price chart
Superinvestors holding MEDP, Q2 2026
2 superinvestors report holding Medpace Holdings, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Giverny Capital
François Rochon
4.5%
Medpace Holdings, Inc.'s share of the portfolio
- Shares
- 253,931
- Value
- $134.5M
Latest insider trades
Open-market purchases and sales by Medpace Holdings, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 25, 2026 (view filing)4:22 PM ET | Sep 23-24 | 2 days | Troendle August J.President & CEO | SSale | −43.9K | $624.01 | −$27.4M | −10.1%389.5K after | 2 lots |
| Sep 23, 2026 (view filing)4:05 PM ET | Sep 21-22 | 2 days | Troendle August J.President & CEO | SSale | −70.9K | $626.62 | −$44.4M | −14.1%433.4K after | 2 lots |
| Sep 21, 2026 (view filing)4:23 PM ET | Sep 17 | 4 days | Troendle August J.President & CEO | SSale | −10.9K | $620.40 | −$6.75M | −2.1%504.3K after | |
| Sep 17, 2026 (view filing)4:39 PM ET | Sep 15-16 | 2 days | Troendle August J.President & CEO | SSale | −24.7K | $621.00 | −$15.4M | −4.6%515.2K after | 2 lots |
| Aug 31, 2026 (view filing)4:11 PM ET | Aug 27 | 4 days | Troendle August J.President & CEO | SSale | −650 | $620.27 | −$403.2K | −0.1%539.9K after | |
| Aug 28, 2026 (view filing)4:32 PM ET | Aug 26 | 2 days | Kraft Robert O.Director | SSale | −3.86K | $617.81 | −$2.38M | −80.2%955 after | |
| Aug 27, 2026 (view filing)4:12 PM ET | Aug 25-26 | 2 days | Troendle August J.President & CEO | SSale | −4.67K | $620.08 | −$2.90M | −0.9%540.5K after | 2 lots |
| Aug 25, 2026 (view filing)4:24 PM ET | Aug 21-24 | 4 days | Troendle August J.President & CEO | SSale | −16.0K | $623.93 | −$9.97M | −2.8%545.2K after | 2 lots |
| Aug 24, 2026 (view filing)4:27 PM ET | Aug 20 | 4 days | Brady Kevin M.CFO & Treasurer | SSale | −3.40K | $625.24 | −$2.13M | −20.9%12.8K after | |
| Aug 21, 2026 (view filing)4:13 PM ET | Aug 19-20 | 2 days | Troendle August J.President & CEO | SSale | −42.8K | $614.30 | −$26.3M | −7.1%561.2K after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Medpace Holdings, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2,498,248 | $1.32B | 0.02% | +27,808+1.1% | Added |
| Price T Rowe Associates Inc | 2,069,677 | $1.10B | 0.11% | +1,780,170+614.9% | Added |
| AQR Capital Management LLC | 1,278,935 | $677.3M | 0.24% | −74,902−5.5% | Reduced |
| Vanguard Portfolio Management LLC | 1,133,357 | $600.2M | 0.03% | +11,668+1.0% | Added |
| Vanguard Capital Management LLC | 1,026,820 | $543.8M | 0.01% | +15,749+1.6% | Added |
| State Street Corp | 710,895 | $376.5M | 0.01% | +28,666+4.2% | Added |
| Geode Capital Management, LLC | 710,465 | $376.3M | 0.02% | −34,641−4.6% | Reduced |
| Wasatch Advisors Inc | 636,595 | $337.1M | 2.21% | −137,336−17.7% | Reduced |
| Invesco Ltd. | 579,241 | $306.8M | 0.02% | +1,667+0.3% | Added |
| Baillie Gifford & Co | 473,211 | $250.6M | 0.23% | −29,980−6.0% | Reduced |